News

Jan 21, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Natera, Nuvei, Corcept Therapeutics, and Agrify and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Natera, Inc. (NASDAQ: NTRA), Nuvei Corporation (NASDAQ: NVEI), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Agrify...
Jan 21, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Natera, Nuvei, Corcept Therapeutics, and Agrify and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Natera, Inc. (NASDAQ: NTRA), Nuvei Corporation (NASDAQ: NVEI), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Agrify...
Jan 21, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Natera, Nuvei, Corcept Therapeutics, and Agrify and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Natera, Inc. (NASDAQ: NTRA), Nuvei Corporation (NASDAQ: NVEI), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Agrify...
Jan 21, 2022 21:00 ET
TASKUS ALERT: Bragar Eagel & Squire, P.C. is Investigating TaskUs, Inc. on Behalf of TaskUs Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TaskUs, Inc. (“TaskUs” or the “Company”) (NASDAQ: TASK) on behalf of TaskUs stockholders. Our investigation concerns whether TaskUs has violated the federal securities laws and/or engaged in other unlawful business practices.
Jan 21, 2022 20:14 ET
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Compensation Committee of the Company’s Board of Directors and the Company’s Board of Directors approved inducement grants of stock options to purchase an aggregate of 5,800 shares of Arcturus’s common stock to one newly-hired employee. The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4)
Jan 21, 2022 20:06 ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SunPower Corporation (SPWR) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of SunPower Corporation (“SunPower” or the “Company”) (NASDAQ: SPWR) investors concerning the Company’s possible violations of the federal securities laws.
Jan 21, 2022 19:54 ET
First Bancshares, Inc. Announces Strong Operating Results for the Quarter and Year Ended December 31, 2021
First Bancshares, Inc. (OTCPink - FstBksh: FBSI) (“Company”), the holding company for Stockmens Bank (“Bank”), today announced its financial results for the quarter and year ended December 31, 2021. For the quarter ended December 31, 2021, the...
Jan 21, 2022 19:50 ET
Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Dividend
Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank division, recently reported unaudited consolidated financial results. For the three months ended...
Jan 21, 2022 19:11 ET
RBB Bancorp Announces Completion of Acquisition of Certain Assets and Liabilities of the Honolulu, Hawaii Branch Office of Bank of the Orient
RBB Bancorp (NASDAQ: RBB) announced today that Royal Business Bank, the wholly-owned subsidiary of RBB, completed the acquisition of the Honolulu, Hawaii branch office the Bank of the Orient on January 14, 2022. Royal Business Bank acquired all the premises and equipment at the Branch, all deposits totaling approximately $81.7 million, selected performing loans totaling approximately $7.4 million, an estimated premium of approximately $3.0 million, for a total consideration of approximately $71.0 million. The transaction acquired all necessary regulatory approvals.
Jan 21, 2022 18:57 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FirstCash, Inc. - FCFS
NEW YORK, Jan. 21, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FirstCash, Inc. ("FirstCash" or the "Company") (NASDAQ: FCFS).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 21, 2022 18:31 ET
Maritime Resources Closes Previously Announced Sale of Royalty Portfolio
Toronto, Ontario--(Newsfile Corp. - January 21, 2022) - Maritime Resources Corp. (TSXV: MAE) ("Maritime" or the "Company") is pleased to announce the closing of its previously announced asset sale transaction with Nomad Royalty Company Ltd. ("Nomad"). Maritime sold a portion of its royalty portfolio in a number of Canadian exploration projects in Quebec, British Columbia and Ontario to Nomad for US$700,000, which was satisfied through the issuance of 96,818 Nomad common shares. As part of the asset sale process, a right of first refusal associated with one of the royalties being sold was exercised and the applicable royalty was sold for approximately $375,000, being the Canadian dollar equivalent of US$300,000.
Jan 21, 2022 18:30 ET
Anacortes Mining Retracts Earlier Announcement of OTCQB Listing
Vancouver, British Columbia--(Newsfile Corp. - January 21, 2022) - Anacortes Mining Corp. (TSXV: XYZ) (OTC Pink: XYZFF) ("Anacortes" or the "Company") wishes to correct its January 13, 2022 announcement that its common shares have been listed for quotation on the OTCQB Venture Market in the United States under the symbol "XYZFF." While Anacortes is now trading on the OTC Pink Current Market, and it has applied to list on the OTCQB Venture Market, the Company's application to list on the OTCQB is still in process.
Jan 21, 2022 18:25 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NRx Pharmaceuticals, Inc, of Class Action Lawsuit and Upcoming Deadline - NRXP; NRXPW
NEW YORK, Jan. 21, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. ("NRx" or the "Company") (NASDAQ: NRXP; NRXPW) and certain of its officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 22-cv-00066, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired NRx securities between June 1, 2021 and November 4, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by
Jan 21, 2022 18:24 ET
FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the treatment of non-hospitalized adult and adolescent patients who are at high risk of progression to severe COVID-19, including hospitalization or death. This approval expands the role of Veklury, which is the antiviral standard of care for the treatment of patients hospitalized with COVID-19. The expanded indication allows for Veklury to be administered in qualified outpatie
Jan 21, 2022 18:12 ET
Ocugen, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced the Compensation...
Jan 21, 2022 18:00 ET
Kaizen Discovery Announces Positive Ruling by The British Columbia Court of Appeal
Vancouver, British Columbia--(Newsfile Corp. - January 21, 2022) - Eric Finlayson, Interim President and Chief Executive Officer of Kaizen Discovery Inc. (TSXV: KZD) otherwise "Kaizen" or "the Company") is pleased to announce that the appeal lodged by AM Gold following the March 22, 2021 dismissal of its legal action against Kaizen by the Supreme Court of British Columbia has itself been dismissed by the British Columbia Court of Appeal, which concluded that no errors were made in the trial judge's reasoning and that "there is no basis upon which this Court should interfere." The judgment is available on the Court of Appeal's website.
Jan 21, 2022 17:53 ET
ELS Announces Tax Treatment of 2021 Distributions
Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as “we,” “us” and “our”) today announced the tax treatment of our 2021 common stock distributions. The following table summarizes the income tax treatment of our 2021 distributions.
Jan 21, 2022 17:50 ET
Gold Springs Resource Corp. 2022 Drilling Program
VANCOUVER, BC / ACCESSWIRE / January 21, 2022 / Gold Springs Resource Corp. (TSX:GRC)(OTCQB:GRCAF) (the "Company" or "GRC"), is pleased to announce its 2022 plan to advance rapidly towards pre-feasibility its 8,000 ha Gold Springs Project located in Nevada and Utah (USA).
Jan 21, 2022 17:37 ET
NexPoint Real Estate Finance, Inc. Announces Pricing of $35 million Offering of 5.75% Senior Unsecured Notes due 2026
DALLAS, Jan. 21, 2022 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE: NREF) ("NREF" or the "Company") announced today the pricing of its underwritten public offering of $35 million aggregate principal amount of its 5.75% Senior Unsecured Notes due 2026 (the "Additional Notes"). The Additional Notes were issued at a price of 100.875% of par with a yield to maturity of 5.514%. The Additional Notes are an additional issuance of the Company's existing $135 million aggregate principal amount of its 5.75% Senior Unsecured Notes due 2026 (the "Existing Notes") and the Additional Notes wil
Jan 21, 2022 17:30 ET
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Specialty Finance Corporation Announce Preferred Dividends
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Specialty Finance Corporation are each pleased to announce the declaration of preferred dividends for the first quarter of 2022, as detailed below.
Jan 21, 2022 17:20 ET
Nouveau Monde Announces Filing of a Prospectus Supplement for At-The-Market Offering
Nouveau Monde Graphite Inc. (“Nouveau Monde” or the “Company”) (TSXV: NOU;
Jan 21, 2022 17:16 ET
ROSEN, A LEADING LAW FIRM, Encourages Chegg, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – CHGG
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chegg, Inc. (NYSE: CHGG) between May 5, 2020 and November 1, 2021, inclusive (the “Class Period”), of the February 22, 2022 lead plaintiff deadline....
Jan 21, 2022 17:15 ET
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that on January 21, 2022 (the “Date of Grant”), the Company approved the grant of inducement...
Jan 21, 2022 17:14 ET
Douglas Emmett Announces 2021 Tax Treatment of Dividends
Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), announced today the tax treatment of its 2021 common stock dividends as described below. Shareholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of Douglas Emmett dividends.
Jan 21, 2022 17:08 ET
PJT Partners Inc. to Report Full Year and Fourth Quarter 2021 Financial Results and Host a Conference Call on February 1, 2022
PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects to release its full year and fourth quarter 2021 financial results on Tuesday morning, February 1, 2022. The earnings release will be available through the Investor Relations section of the PJT Partners website at www.pjtpartners.com.
Jan 21, 2022 17:03 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embark Technology, Inc. - EMBK
NEW YORK, Jan. 21, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Embark Technology, Inc. ("Embark" or the "Company") (NASDAQ: EMBK).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 21, 2022 17:00 ET
Archer Appoints Mark Mesler as Chief Financial Officer
Archer Aviation Inc. (NYSE: ACHR) today announced the appointment of Mark Mesler as the Company’s Chief Financial Officer.
Jan 21, 2022 17:00 ET
OOOOO Announces Issuance of First Installment Payment Shares Under Services Agreement with AGORACOM
OOOOO Entertainment Commerce Limited (“OOOOO”) (OOOO:TSXV, OOOOF:OTCQB), a mobile commerce platform, is pleased to announce that further to its news release on January 17, 2022, the Company has now received conditional approval from the TSX Venture...
Jan 21, 2022 17:00 ET
Performance Shipping Inc. Announces Date for its 2022 Annual General Meeting of Shareholders and Proposed Changes to Board of Directors
Performance Shipping Inc. (NASDAQ: PSHG), (the “Company”), a global shipping company specializing in the ownership of tanker vessels, announced today that its Board of Directors (the “Board”) has scheduled the Company’s 2022 annual general meeting...
Jan 21, 2022 17:00 ET
TIMIA Capital Announces the Close of the Non-Brokered Private Placement
/~NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES~/
Jan 21, 2022 16:59 ET
Pennsylvania American Water Reminds Customers to Act Now to Prevent Frozen Pipes Later
With weather forecasters predicting cold temperatures very soon, Pennsylvania American Water advises homeowners to prepare their homes now to prevent frozen and damaged household pipes. The company recently released a new Winter Tips video to help customers protect the pipes in their homes.
Jan 21, 2022 16:56 ET
MINERAL MOUNTAIN ANNOUNCES APPOINTMENT OF CFO
MMV-TSX-VMNRLF-OTCQBM8M:FRANKFURT
Jan 21, 2022 16:54 ET
International Seaways to Participate in Capital Link Company Presentation Series
International Seaways, Inc. (NYSE: INSW) (the “Company” or “INSW”), one of the largest tanker companies worldwide providing energy transportation services for crude oil and petroleum products announced today that it will participate in Capital Link Company Presentation Series.
Jan 21, 2022 16:53 ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors and Encourages Investors to Contact
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ:
Jan 21, 2022 16:50 ET
Mercer International Inc. Announces Completion of CDN$160 Million Revolving Credit Facility
Mercer International Inc., or "Mercer", (Nasdaq: MERC) today announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CDN$160 million joint asset-backed revolving credit facility (the "New Facility") with...
Jan 21, 2022 16:46 ET
Oxford Lane Capital Corp. Schedules Third Fiscal Quarter Earnings Release and Conference Call for January 28, 2022
Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) announced today that it will hold a conference call to discuss its third fiscal quarter earnings on Friday, January...
Jan 21, 2022 16:46 ET
Oxford Lane Capital Corp. Schedules Third Fiscal Quarter Earnings Release and Conference Call for January 28, 2022
Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) announced today that it will hold a conference call to discuss its third fiscal quarter earnings on Friday, January...
Jan 21, 2022 16:46 ET
Oxford Lane Capital Corp. Schedules Third Fiscal Quarter Earnings Release and Conference Call for January 28, 2022
Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) announced today that it will hold a conference call to discuss its third fiscal quarter earnings on Friday, January...
Jan 21, 2022 16:46 ET
Oxford Lane Capital Corp. Schedules Third Fiscal Quarter Earnings Release and Conference Call for January 28, 2022
Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) announced today that it will hold a conference call to discuss its third fiscal quarter earnings on Friday, January...
Jan 21, 2022 16:46 ET
Oxford Lane Capital Corp. Schedules Third Fiscal Quarter Earnings Release and Conference Call for January 28, 2022
Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) announced today that it will hold a conference call to discuss its third fiscal quarter earnings on Friday, January...
Jan 21, 2022 16:44 ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Conta
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:
Jan 21, 2022 16:37 ET
InvenTrust Properties Corp. Announces Fourth Quarter 2021 Earnings Release and Conference Call Dates
InvenTrust Properties Corp. (“InvenTrust” or the “Company”) (NYSE: IVT) today announced that it will report its fourth quarter 2021 earnings results on February 10, 2022, after the market closes. The Company’s earnings release and any supplemental information will be posted on the Investor Relations section of the Company’s website –
Jan 21, 2022 16:31 ET
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of eHealth, Inc. (EHTH) Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired eHealth, Inc. (“eHealth” or the “Company”) (NASDAQ: EHTH)...
Jan 21, 2022 16:31 ET
Avista files multiyear rate plan in Washington
Today Avista (NYSE: AVA) has filed a multiyear rate plan with the Washington Utilities and Transportation Commission (WUTC or Commission) that would allow the Company to recover costs for fixed expenses and ongoing investments to infrastructure,...
Jan 21, 2022 16:31 ET
Beachbody on Demand Interactive Wins Good Housekeeping 2022 Fitness Award
The Beachbody Company, Inc. (“Beachbody”) (NYSE: BODY), a leader in subscription health and wellness, announced today its live interactive premium subscription tier, Beachbody On Demand Interactive (or “BODi” – pronounced “body”) has been selected as a winner of the
Jan 21, 2022 16:30 ET
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF REGULATED INFORMATIONMontrouge, France, January 21, 2022 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage...
Jan 21, 2022 16:30 ET
Michael P. Carlson Joins Trustmark as Executive Vice President and Chief Risk Officer
Trustmark Corporation (NASDAQGS:TRMK) is pleased to announce that Michael P. (Mike) Carlson has joined Trustmark as Executive Vice President and Chief Risk Officer of Trustmark National Bank, and will be responsible for Trustmark’s compliance and risk functions. He reports to Granville Tate, Jr., EVP and Chief Administrative Officer, who also previously held the Chief Risk Officer role prior to Mr. Carlson assuming the position.
Jan 21, 2022 16:30 ET
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients. Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward.
Jan 21, 2022 16:30 ET
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients. Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward.
Jan 21, 2022 16:26 ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Berkeley Lights, Inc. (BLI), Cloopen Group Holding Limited (RAAS),
The law firm of Kirby McInerney LLP reminds investors that securities class action lawsuits have been filed on behalf of investors in securities of Berkeley Lights, Inc., Cloopen Group Holding Limited, and Paysafe Limited. Investors have until the...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.